LLOYD W KLEIN

Allopathic & Osteopathic Physicians|Internal Medicine|Cardiovascular Disease SAN FRANCISCO, CA NPI 1063495166

General Payments — all program years on this page

$171,227.45

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 122
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $12,066.93 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Novo Nordisk AS $11,666.9314
Medtronic, Inc. $400.001

By program year

Program yearAmountRecords
2018 $26,663.7727
2019 $11,862.0311
2020 $20,377.5012
2021 $99,736.0852
2022 $322.144
2023 $199.001
2024 $12,066.9315

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1096570934 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1096707146 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1096724446 Novo Nordisk Inc $32.27 05/29/2024 Education Undisputed 01/23/2026 View at CMS
1096920112 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1097116916 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1097322525 Novo Nordisk Inc $1,938.00 09/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097330898 Novo Nordisk Inc $1,938.00 08/30/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097489875 Novo Nordisk Inc $3,624.50 04/01/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097490076 Novo Nordisk Inc $1,938.00 06/26/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097527002 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1097661751 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1097691561 Novo Nordisk Inc $1,938.00 10/29/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1097731239 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1097830344 Novo Nordisk Inc $32.27 09/10/2024 Education Undisputed 01/23/2026 View at CMS
1112074519 Medtronic, Inc. $400.00 10/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.